Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Symptom Flare Up"" wg kryterium: Temat


Tytuł:
The mode of delivery does not influence the occurrence of post-partum perianal disease flares in patients with inflammatory bowel disease.
Autorzy:
Otero-Piñerio AM; Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Aykun N; Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Maspero M; Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Holubar S; Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Hull T; Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Lipman J; Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Steele SR; Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Lightner AL; Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA. .; National Center for Regenerative Medicine, Cleveland, OH, USA. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Jan 16; Vol. 24 (1), pp. 34. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article
MeSH Terms:
Crohn Disease*/complications
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/surgery
Humans ; Female ; Pregnancy ; Cesarean Section ; Symptom Flare Up ; Postpartum Period
Czasopismo naukowe
Tytuł:
The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab: A Systematic Review and Meta-Analysis.
Autorzy:
Ko PH; School of Medicine, Tzuchi University, Hualien 970, Taiwan.; Division of Gastroenterology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi 622, Taiwan.
Kuo MH; Department of Pharmacy, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi 622, Taiwan.
Kao IT; Department of Pharmacy, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi 622, Taiwan.
Wu CY; Department of Pharmacy, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi 622, Taiwan.
Tseng CW; School of Medicine, Tzuchi University, Hualien 970, Taiwan.; Division of Gastroenterology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi 622, Taiwan.
Shao SC; Department of Pharmacy, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Jan 03; Vol. 16 (1). Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Antibodies, Monoclonal, Humanized*/adverse effects
Arthritis, Rheumatoid*/complications
Arthritis, Rheumatoid*/drug therapy
Hepatitis A*
Hepatitis B, Chronic*
Humans ; Antiviral Agents ; Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; Hepatitis B virus/genetics ; Symptom Flare Up
Czasopismo naukowe
Tytuł:
Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus.
Autorzy:
Piyaphanee N; Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Charuvanij S; Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Thepveera S; Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Toh ZQ; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Parkville, VIC, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia.
Licciardi PV; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Parkville, VIC, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia.
Pattaragarn A; Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Wongprompitak P; Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Boonnak K; Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Pheerapanyawaranun C; Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Chokephaibulkit K; Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (5), pp. 450-461. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/drug therapy
Humans ; Adolescent ; BNT162 Vaccine ; COVID-19 Vaccines/adverse effects ; Symptom Flare Up ; Prednisolone ; Immunosuppressive Agents/adverse effects ; Immunoglobulin G ; Antibodies, Viral ; Vaccination ; Immunogenicity, Vaccine
Czasopismo naukowe
Tytuł:
Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission.
Autorzy:
Bodini G; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Ghezzi A; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Pasta A; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Marabotto E; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Calabrese F; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Facchini C; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Demarzo MG; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Giannini EG; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Pokaż więcej
Źródło:
Journal of gastrointestinal and liver diseases : JGLD [J Gastrointestin Liver Dis] 2023 Dec 22; Vol. 32 (4), pp. 438-443. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Journal Article
MeSH Terms:
Colitis, Ulcerative*/therapy
Colitis, Ulcerative*/drug therapy
Crohn Disease*/diagnosis
Crohn Disease*/therapy
Inflammatory Bowel Diseases*
Humans ; Leukocyte L1 Antigen Complex ; Symptom Flare Up ; Biomarkers ; Inflammation ; Feces ; Remission Induction ; Escherichia coli
Czasopismo naukowe
Tytuł:
A dose-escalation study of HP501, a highly selective URAT1 inhibitor, in male Chinese patients with hyperuricemia.
Autorzy:
Ding R; Institute of Drug Clinical Trial/GCP Center, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Deng X; Clinical Pharmacology Research Center, Chengdu Fifth People's Hospital, Chengdu, 610041, Sichuan, China.
Chen L; Institute of Drug Clinical Trial/GCP Center, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Zhen Y; Institute of Drug Clinical Trial/GCP Center, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Li X; Hinova Pharmaceuticals Inc., Chengdu, 610041, Sichuan, China.
Xiong T; Institute of Drug Clinical Trial/GCP Center, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Zhang Y; Institute of Drug Clinical Trial/GCP Center, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Chen H; Institute of Drug Clinical Trial/GCP Center, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Hu X; Institute of Drug Clinical Trial/GCP Center, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Li Y; Institute of Drug Clinical Trial/GCP Center, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Zhou Y; Hinova Pharmaceuticals Inc., Chengdu, 610041, Sichuan, China.
Jiang F; Department of Cardiology, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan, China.
Peng Q; Department of Cardiology, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan, China. .
Wang X; Department of Endocrinology, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 14; Vol. 13 (1), pp. 22190. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
Hyperuricemia*/drug therapy
Gout*/drug therapy
Humans ; Male ; Uric Acid ; Symptom Flare Up ; Uricosuric Agents/therapeutic use ; China
Czasopismo naukowe
Tytuł:
Cohort study investigating gout flares and management in UK general practice.
Autorzy:
Finnikin S; Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK. .
Mallen CD; Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, UK.
Roddy E; Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, UK.; Haywood Academic Rheumatology Centre, Midlands Partnership NHS Foundation Trust, Stoke-On-Trent, UK.
Pokaż więcej
Źródło:
BMC primary care [BMC Prim Care] 2023 Nov 22; Vol. 24 (1), pp. 246. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gout*/diagnosis
Gout*/drug therapy
Gout*/epidemiology
General Practice*
Humans ; Male ; Uric Acid/therapeutic use ; Gout Suppressants/therapeutic use ; Cohort Studies ; Symptom Flare Up ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł:
Steroid-free flare management of a severe cutaneous lupus flare with anifrolumab.
Autorzy:
Heide M; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany.
von Figura A; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany.
Rademacher JG; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany.
Wincup C; Department of Rheumatology, King's College Hospital, London, UK.; Department of Rheumatology, Division of Medicine, Rayne Building, University College London, London, UK.
Tampe B; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany.
Korsten P; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany.; Department of Rheumatology and Clinical Immunology, St Josef-Stift Sendenhorst, Sendenhorst, Germany.
Pokaż więcej
Źródło:
Lupus [Lupus] 2023 Nov; Vol. 32 (13), pp. 1585-1587. Date of Electronic Publication: 2023 Oct 27.
Typ publikacji:
Letter
MeSH Terms:
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Cutaneous*/diagnosis
Lupus Erythematosus, Cutaneous*/drug therapy
Humans ; Symptom Flare Up ; Antibodies, Monoclonal, Humanized/therapeutic use
Opinia redakcyjna
Tytuł:
Machine learning: Predicting hospital length of stay in patients admitted for lupus flares.
Autorzy:
Grovu R; Internal Medicine Department, Staten Island University Hospital, Staten Island, NY, USA.
Huo Y; Department of Engineering, University of Massachusetts, Dartmouth, MA, USA.
Nguyen A; Medicine Department, Harvard Medical School, Boston, MA, USA.
Mourad O; Internal Medicine Department, Staten Island University Hospital, Staten Island, NY, USA.
Pan Z; Medicine Department, Duke-NUS Medical School, Singapore.
El-Gharib K; Internal Medicine Department, Staten Island University Hospital, Staten Island, NY, USA.
Wei C; Internal Medicine Department, Staten Island University Hospital, Staten Island, NY, USA.
Mustafa A; Internal Medicine Department, Staten Island University Hospital, Staten Island, NY, USA.
Quan T; Medicine Department, George Washington University School of Medicine, Washington, DC, USA.
Slobodnick A; Rheumatology Department, Staten Island University Hospital, Staten Island, NY, USA.
Pokaż więcej
Źródło:
Lupus [Lupus] 2023 Oct; Vol. 32 (12), pp. 1418-1429. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/therapy
Humans ; Length of Stay ; Symptom Flare Up ; Hospitalization ; Machine Learning ; Hospitals
Czasopismo naukowe
Tytuł:
New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis.
Autorzy:
Sakamoto S; Division of Respiratory Medicine, Toho University Omori Medical Center, Ota-ku Omori nisi 6-11-1, Tokyo, 143-8541, Japan. .
Shimizu H; Division of Respiratory Medicine, Toho University Omori Medical Center, Ota-ku Omori nisi 6-11-1, Tokyo, 143-8541, Japan.
Isshiki T; Division of Respiratory Medicine, Toho University Omori Medical Center, Ota-ku Omori nisi 6-11-1, Tokyo, 143-8541, Japan.
Nakamura Y; Division of Respiratory Medicine, Toho University Omori Medical Center, Ota-ku Omori nisi 6-11-1, Tokyo, 143-8541, Japan.
Usui Y; Division of Respiratory Medicine, Toho University Omori Medical Center, Ota-ku Omori nisi 6-11-1, Tokyo, 143-8541, Japan.
Kurosaki A; Department of Diagnostic Radiology, Fukujuji Hospital, Kiyose, Tokyo, Japan.
Isobe K; Division of Respiratory Medicine, Toho University Omori Medical Center, Ota-ku Omori nisi 6-11-1, Tokyo, 143-8541, Japan.
Takai Y; Division of Respiratory Medicine, Toho University Omori Medical Center, Ota-ku Omori nisi 6-11-1, Tokyo, 143-8541, Japan.
Homma S; Department of Advanced and Integrated Interstitial Lung Diseases Research, School of Medicine, Toho University, Ota-ku, Tokyo, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jan 21; Vol. 12 (1), pp. 1134. Date of Electronic Publication: 2022 Jan 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Symptom Flare Up*
Idiopathic Pulmonary Fibrosis/*mortality
Respiratory Insufficiency/*mortality
Aged ; Aged, 80 and over ; Biomarkers/blood ; Female ; Follow-Up Studies ; Humans ; Idiopathic Pulmonary Fibrosis/blood ; Idiopathic Pulmonary Fibrosis/complications ; Idiopathic Pulmonary Fibrosis/diagnosis ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Models, Statistical ; ROC Curve ; Respiratory Insufficiency/etiology ; Retrospective Studies ; Risk Assessment/methods ; Risk Assessment/statistics & numerical data
Czasopismo naukowe
Tytuł:
Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study.
Autorzy:
Park J; Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
Yoon H; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Shin CM; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Park YS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Kim N; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Lee DH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jan 21; Vol. 17 (1), pp. e0262571. Date of Electronic Publication: 2022 Jan 21 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Symptom Flare Up*
Inflammatory Bowel Diseases/*physiopathology
Adult ; Air Travel ; Colitis/etiology ; Colitis/physiopathology ; Colitis, Ulcerative/etiology ; Colitis, Ulcerative/physiopathology ; Crohn Disease/etiology ; Crohn Disease/physiopathology ; Feces/chemistry ; Female ; Humans ; Inflammatory Bowel Diseases/complications ; Leukocyte L1 Antigen Complex/analysis ; Male ; Prognosis ; Prospective Studies
Czasopismo naukowe
Tytuł:
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication.
Autorzy:
Hügle B; German Center for Pediatric and Adolescent Rheumatology, Gehfeldstrasse 24, 82467, Garmisch-Partenkirchen, Germany. .
Krumrey-Langkammerer M; German Center for Pediatric and Adolescent Rheumatology, Gehfeldstrasse 24, 82467, Garmisch-Partenkirchen, Germany.
Haas JP; German Center for Pediatric and Adolescent Rheumatology, Gehfeldstrasse 24, 82467, Garmisch-Partenkirchen, Germany.
Pokaż więcej
Źródło:
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2021 Nov 29; Vol. 19 (1), pp. 163. Date of Electronic Publication: 2021 Nov 29.
Typ publikacji:
Journal Article
MeSH Terms:
Symptom Flare Up*
Arthritis, Juvenile/*physiopathology
COVID-19/*physiopathology
Adolescent ; Antibodies, Monoclonal/therapeutic use ; Antirheumatic Agents/therapeutic use ; Arthritis, Juvenile/complications ; Arthritis, Juvenile/drug therapy ; Arthritis, Juvenile/metabolism ; Azetidines/therapeutic use ; Blood Sedimentation ; C-Reactive Protein/metabolism ; COVID-19/complications ; Child ; Etanercept/therapeutic use ; Female ; Humans ; Male ; Methotrexate/therapeutic use ; Purines/therapeutic use ; Pyrazoles/therapeutic use ; Remission Induction ; SARS-CoV-2 ; Sulfonamides/therapeutic use ; Uveitis/complications ; Uveitis/physiopathology
Czasopismo naukowe
Tytuł:
Urate-lowering therapy following a treat-to-target continuation strategy compared to a treat-to-avoid-symptoms discontinuation strategy in gout patients in remission (GO TEST Finale): study protocol of a multicentre pragmatic randomized superiority trial.
Autorzy:
Peeters IR; Department of Rheumatology, Sint Maartenskliniek, Ubbergen, the Netherlands. .; Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. .
den Broeder AA; Department of Rheumatology, Sint Maartenskliniek, Ubbergen, the Netherlands.; Department of Rheumatology, Radboud University Medical Center, Nijmegen, the Netherlands.
Taylor WJ; Department of Medicine, University of Otago Wellington, Newtown, Wellington, New Zealand.
den Broeder N; Department of Rheumatology, Sint Maartenskliniek, Ubbergen, the Netherlands.; Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Flendrie M; Department of Rheumatology, Sint Maartenskliniek, Ubbergen, the Netherlands.
van Herwaarden N; Department of Rheumatology, Sint Maartenskliniek, Ubbergen, the Netherlands.; Department of Pharmacology, Radboud University Medical Center, Nijmegen, the Netherlands.
Pokaż więcej
Źródło:
Trials [Trials] 2023 Apr 19; Vol. 24 (1), pp. 282. Date of Electronic Publication: 2023 Apr 19.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Gout*/diagnosis
Gout*/drug therapy
Humans ; Gout Suppressants/adverse effects ; Kidney ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Symptom Flare Up ; Uric Acid ; Pragmatic Clinical Trials as Topic
Czasopismo naukowe
Tytuł:
Pregnancy outcomes among Egyptian women with systemic lupus erythematosus: A prospective cohort study.
Autorzy:
Mokbel A; Department of Rheumatology and Rehabilitation, Kasr-Alainy School of Medicine, Cairo University, Cairo, Egypt.; Department of Health Research Methods, McMaster University, Hamilton, Canada.
Attia DH; Department of Rheumatology and Rehabilitation, Kasr-Alainy School of Medicine, Cairo University, Cairo, Egypt.
Zayed HS; Department of Rheumatology and Rehabilitation, Kasr-Alainy School of Medicine, Cairo University, Cairo, Egypt.
Eesa Naeem N; Department of Rheumatology and Rehabilitation, Kasr-Alainy School of Medicine, Cairo University, Cairo, Egypt.
Mahmoud G; Department of Rheumatology and Rehabilitation, Kasr-Alainy School of Medicine, Cairo University, Cairo, Egypt.
Riad R; Department of Obstetrics and Gynecology, Kasr-Alainy School of Medicine, Cairo University, Cairo, Egypt.
Abou Elewa S; Department of Obstetrics and Gynecology, Kasr-Alainy School of Medicine, Cairo University, Cairo, Egypt.
Youssef M; Department of Obstetrics and Gynecology, Kasr-Alainy School of Medicine, Cairo University, Cairo, Egypt.
Haggag H; Department of Obstetrics and Gynecology, Kasr-Alainy School of Medicine, Cairo University, Cairo, Egypt.
Mohamed SS; Department of Rheumatology and Rehabilitation, Kasr-Alainy School of Medicine, Cairo University, Cairo, Egypt.
Pokaż więcej
Źródło:
Lupus [Lupus] 2023 Apr; Vol. 32 (4), pp. 521-530. Date of Electronic Publication: 2023 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/epidemiology
Pre-Eclampsia*/epidemiology
Pregnancy Complications*/diagnosis
Antiphospholipid Syndrome*/complications
Antiphospholipid Syndrome*/epidemiology
Pregnancy ; Infant, Newborn ; Humans ; Female ; Young Adult ; Adult ; Pregnancy Outcome/epidemiology ; Prospective Studies ; Egypt/epidemiology ; Symptom Flare Up ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Short- and mid-term outcomes in systemic lupus erythematosus patients presenting with disease exacerbation after SARS-CoV-2 mRNA vaccination: A cohort study from Puerto Rico.
Autorzy:
González-Meléndez A; Division of Rheumatology, Department of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.
Báez-Negrón L; Division of Rheumatology, Department of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.
Ríos-Rivera R; Division of Rheumatology, Department of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.
Franco-O'Connell AS; Division of Rheumatology, Department of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.
Nieves-Plaza M; Department of Medicine, Universidad Central Del Caribe, Bayamón, Puerto Rico.
Vilá LM; Division of Rheumatology, Department of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.
Pokaż więcej
Źródło:
Lupus [Lupus] 2023 Apr; Vol. 32 (4), pp. 571-579. Date of Electronic Publication: 2023 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
COVID-19*/complications
COVID-19 Vaccines*/adverse effects
Lupus Erythematosus, Systemic*/complications
Humans ; Cohort Studies ; Disease Progression ; Puerto Rico ; RNA, Messenger ; SARS-CoV-2 ; Severity of Illness Index ; Symptom Flare Up ; Vaccination/adverse effects
Czasopismo naukowe
Tytuł:
Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study.
Autorzy:
Fasano S; Rheumatology Unit, University of Campania 'Luigi Vanvitelli', Caserta, Italy.
Coscia MA; Rheumatology Unit, University of Campania 'Luigi Vanvitelli', Caserta, Italy.
Pierro L; Rheumatology Unit, University of Campania 'Luigi Vanvitelli', Caserta, Italy.
Ciccia F; Rheumatology Unit, University of Campania 'Luigi Vanvitelli', Caserta, Italy.
Pokaż więcej
Źródło:
Lupus [Lupus] 2021 May; Vol. 30 (6), pp. 991-997. Date of Electronic Publication: 2021 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Symptom Flare Up*
Glucocorticoids/*administration & dosage
Lupus Erythematosus, Systemic/*drug therapy
Withholding Treatment/*statistics & numerical data
Adult ; Cohort Studies ; Databases, Factual ; Disease Management ; Disease Progression ; Female ; Humans ; Hydroxychloroquine/therapeutic use ; Italy ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Proportional Hazards Models ; Remission Induction/methods ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis.
Autorzy:
Das U; Department of Nephrology, Nizam's Institute of Medical Sciences, Hyderabad, India.
Patel R; Department of Nephrology, Nizam's Institute of Medical Sciences, Hyderabad, India.
Guditi S; Department of Nephrology, Nizam's Institute of Medical Sciences, Hyderabad, India.
Taduri G; Department of Nephrology, Nizam's Institute of Medical Sciences, Hyderabad, India.
Pokaż więcej
Źródło:
Lupus [Lupus] 2021 May; Vol. 30 (6), pp. 876-883. Date of Electronic Publication: 2021 Feb 20.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Symptom Flare Up*
Immunosuppressive Agents/*therapeutic use
Kidney/*pathology
Lupus Nephritis/*drug therapy
Lupus Nephritis/*pathology
Adult ; Biopsy ; Female ; Humans ; India ; Kaplan-Meier Estimate ; Maintenance Chemotherapy ; Male ; Remission Induction ; Retrospective Studies ; Risk Assessment/methods ; Risk Factors ; Severity of Illness Index ; Withholding Treatment ; Young Adult
Czasopismo naukowe
Tytuł:
Can pain flares in knee osteoarthritis be predicted?
Autorzy:
Atukorala I; Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Pathmeswaran A; Department of Public Health, University of Kelaniya, Ragama, Sri Lanka.
Makovey J; Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia.
Metcalf B; Centre for Health, Exercise and Sports Medicine, Department of Physiotherapy, School of Health Sciences, University of Melbourne, Melbourne, Australia.
Bennell KL; Centre for Health, Exercise and Sports Medicine, Department of Physiotherapy, School of Health Sciences, University of Melbourne, Melbourne, Australia.
March L; Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia.; Rheumatology Department, Royal North Shore Hospital, Sydney, Australia.
Chang T; Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Zhang Y; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Hunter DJ; Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia.; Rheumatology Department, Royal North Shore Hospital, Sydney, Australia.
Pokaż więcej
Źródło:
Scandinavian journal of rheumatology [Scand J Rheumatol] 2021 May; Vol. 50 (3), pp. 198-205. Date of Electronic Publication: 2021 Jan 20.
Typ publikacji:
Journal Article
MeSH Terms:
Symptom Flare Up*
Knee Joint/*physiopathology
Osteoarthritis, Knee/*diagnosis
Aged ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Osteoarthritis, Knee/physiopathology ; Pain Measurement ; Risk Factors ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe asthma.
Autorzy:
Ko HK; Department of Chest Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, 112, Taiwan, ROC.; School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
Cheng SL; Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan, ROC.; Department of Chemical Engineering and Materials Science, Yuan Ze University, Zhongli, Taoyuan, Taiwan, ROC.
Lin CH; Division of Chest Medicine, Changhua Christian Hospital, Changhua, Taiwan, ROC.; College of Health Sciences, Chang Jung Christian University, Tainan, Taiwan, ROC.
Lin SH; Division of Chest Medicine, Changhua Christian Hospital, Changhua, Taiwan, ROC.
Hsiao YH; Department of Chest Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, 112, Taiwan, ROC.; School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
Su KC; Department of Chest Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, 112, Taiwan, ROC.; School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
Yu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, ROC.
Wang HC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, ROC.
Sheu CC; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, ROC.; Department of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC.
Chiu KC; Division of Chest, Department of Internal Medicine, Poh-Ai Hospital Luodong, No. 83, Nanchang St., Luodong Township, 265, Yilan, Taiwan, ROC. .
Perng DW; Department of Chest Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, 112, Taiwan, ROC. .; School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Apr 19; Vol. 11 (1), pp. 8425. Date of Electronic Publication: 2021 Apr 19.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Asthma*/drug therapy
Asthma*/pathology
Symptom Flare Up*
Cytokines/*blood
Tryptases/*blood
Adrenal Cortex Hormones/therapeutic use ; Aged ; Anti-Asthmatic Agents/therapeutic use ; Biomarkers ; Eosinophilia ; Female ; Humans ; Leukocyte Count ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Thymic Stromal Lymphopoietin
Czasopismo naukowe
Tytuł:
Prediction of disease flare by biomarkers after discontinuing biologics in patients with rheumatoid arthritis achieving stringent remission.
Autorzy:
Kameda H; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, 2-22-36 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan. .
Hirata A; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, 2-22-36 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan.
Katagiri T; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, 2-22-36 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan.
Takakura Y; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, 2-22-36 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan.
Inoue Y; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, 2-22-36 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan.
Takenaka S; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, 2-22-36 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan.
Ito H; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, 2-22-36 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan.
Mizushina K; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, 2-22-36 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan.
Ogura T; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, 2-22-36 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Mar 25; Vol. 11 (1), pp. 6865. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Severity of Illness Index*
Symptom Flare Up*
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Biological Products/*therapeutic use
Biomarkers/*analysis
Withholding Treatment/*statistics & numerical data
Aged ; Arthritis, Rheumatoid/pathology ; Female ; Humans ; Male ; Middle Aged ; Remission Induction ; Treatment Outcome
Czasopismo naukowe
Tytuł:
How do systemic lupus erythematosus patients with very-long disease duration present? Analysis of a monocentric cohort.
Autorzy:
Signorini V; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Tani C; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Elefante E; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Carli L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Stagnaro C; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Zucchi D; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Parma A; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Vagelli R; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Ferro F; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Mosca M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Pokaż więcej
Źródło:
Lupus [Lupus] 2021 Mar; Vol. 30 (3), pp. 439-447. Date of Electronic Publication: 2021 Jan 07.
Typ publikacji:
Journal Article
MeSH Terms:
Disease Progression*
Quality of Life*
Remission Induction*
Symptom Flare Up*
Lupus Erythematosus, Systemic/*complications
Adult ; Female ; Glucocorticoids/therapeutic use ; Humans ; Lupus Erythematosus, Systemic/drug therapy ; Male ; Middle Aged ; Retrospective Studies ; Risk Assessment ; Severity of Illness Index ; Time Factors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies